Lactobacillus acidophilus/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases alanine aminotransferase
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Compared with the sham group, serum ALT, AST, TBA, ALP, TBIL, and liver index were significantly increased in the BDL group, while L. acidophilus treatment significantly reduced (, Supplementary Figure 4a-c), which is consistently with Mdr2−/− mice (Supplementary Figure 5a-d).”
Quoted verbatim from Lactobacillus acidophilus ameliorates cholestatic liver injury through inhibiting bile acid synthesis and promoting bile acid excretion.. - Study
- animal · not in humans
- Duration
- 9 days
- Dose
- live L. acidophilus 10^8 CFU in 200 microlitres per day by oral gavage for 9 days after bile duct ligation
- Population
- Male C57BL/6J mice with bile-duct-ligation cholestatic liver injury (n = 5 to 6 per group); L. acidophilus versus BDL without treatment
Lactobacillus acidophilus ameliorates cholestatic liver injury through inhibiting bile acid synthesis and promoting bile acid excretion.2024PMID:39205654Permalink
Keep reading
- Everything the graph holds on Lactobacillus acidophilus
- Every compound studied against Alanine aminotransferase
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M45SWTC1QSZAGR0KETF3SQ7G